For example, although a SCN1A splicevariant with faster recovery from inactivation has been lost during evolution, probably toprotect from a gain of function effect, in the case of a pathological hyperactivitycondition such as epilepsy, its reintroduction in interneurons may be therapeutic. This evidence concerns the gene SCN1A and epilepsy.